Most academic journals are researchers talking to researchers, butThe American Journal of Managed Care® (AJMC®) is typically researchers talking to the community, says Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy; director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School; and co-editor-in-chief of AJMC®.
Most academic journals are researchers talking to researchers, butThe American Journal of Managed Care® (AJMC®) is typically researchers talking to the community, says Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy; director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School; and co-editor-in-chief of AJMC®.
Transcript
What role does AJMC®play in informing stakeholders?
We live in an era of fake news. The American Journal of Managed Care® is dedicated to the true news, to holding up the bar of rigor, to look at a range of different topics related to managed care. We reject over two-thirds of the manuscripts that are submitted and we hold the ones that we accept to a high bar of academic rigor.
When folks want to know broadly what’s going on, they can turn to a lot of different sources. Many of those sources have vested interests in what they’re saying. Many of those sources haven’t actually studied rigorously what they’ve done. There’s often a notion that this is good enough information for our decision-making process. I don’t want to be too negative on that basic viewpoint, but the role of The American Journal of Managed Care® is to identify when we really have strong scientific evidence on a range of topics, that’s typically generated by academics or certainly people working as researchers, and then the journal becomes a bridge.
The audience includes academics, but it includes a much wider group of people, so we bridge sort of the research generation community and the research consumption community. Most academic journals are researchers talking to researchers. We’re typically researchers talking to the community. We hold the same standards of academic rigor except we try and present that in a way that’s useful to nonacademics, and we try and publish on topics that are important to nonacademics.
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Recent T1D Research Contradicts Common Assumptions About Patients
November 15th 2023Michael Fang, PhD, researcher and assistant professor in the division of Cardiovascular and Clinical Epidemiology at Johns Hopkins University, discussed recent findings in the type 1 diabetes (T1D) space that may alter the way providers address diabetes diagnoses.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen